NBIX - Neurocrine Biosciences, Inc.
IEX Last Trade
127.06
-1.370 -1.078%
Share volume: 1,236,878
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$128.43
-1.37
-1.07%
Summary score
51%
Profitability
68%
Dept financing
9%
Liquidity
51%
Performance
44%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.51%
Return on assets
3.25%
Return on sales
19.97%
Return on invested capital
11.53%
Total debt ratio
32%
Debt ratio change over timeo
0.45%
Current Ratio
3.59%
Quick Ratio
3.5%
Cash Position Ratio
2.55%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.79%
Return on assets
4.27%
Return on sales
25.74%
Return on invested capital
10.28%
Total debt ratio
29.11%
Debt ratio change over timeo
2.86%
Current Ratio
2.89%
Quick Ratio
2.82%
Cash Position Ratio
1.87%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
2.59%
Return on assets
4.48%
Return on sales
25.06%
Return on invested capital
5.26%
Total debt ratio
24.08%
Debt ratio change over time
3.58%
Current Ratio
4.19%
Quick Ratio
4.08%
Cash Position Ratio
2.61%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
1.9%
Return on assets
-91.13%
Return on sales
-38.02%
Return on invested capital
127.83%
Total debt ratio
44.79%
Debt ratio change over time
0.45%
Current Ratio
20.2%
Quick Ratio
19.79%
Cash Position Ratio
15.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NBIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 3.51% | 15.05% | 35.64% | 7.13% |
| Return on assets | 3.25% | 2.88% | 3.13% | 5.53% |
| Return on sales | 19.97% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 11.53% | 2.57% | 5.37% | 18.48% |
| Profitability | 45% | 45% | 66% | 80% |
| Total debt ratio | 32% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | 0.45% | 326.95% | -8.44% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.89% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.82% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 1.87% | 0.39% | 1.05% | 2.91% |
| Liquididy | 67% | 13% | 29% | 71% |
| Short-term ratios | NBIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 3.79% | 13.14% | 10.88% | 4.07% |
| Return on assets | 4.27% | 2.1% | 1.54% | 3.03% |
| Return on sales | 25.74% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 10.28% | 1.95% | 2.74% | 9.55% |
| Profitability | 78% | 60% | 52% | 74% |
| Total debt ratio | 29.11% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | 2.86% | 51.04% | -101.54% | 1.43% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 2.89% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.82% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 1.87% | 0.39% | 1.05% | 2.91% |
| Liquididy | 45% | 12% | 27% | 75% |